Fetal RHD Screening in RH1 Negative Pregnant Women: Experience in Switzerland

Autor: Bernd Schimanski, Rahel Kräuchi, Jolanda Stettler, Sofia Lejon Crottet, Christoph Niederhauser, Frederik Banch Clausen, Stefano Fontana, Markus Hodel, Sofia Amylidi-Mohr, Luigi Raio, Claire Abbal, Christine Henny

Publikováno v: Biomedicines, Vol 11, Iss 10, p 2646 (2023)

RH1 incompatibility between mother and fetus can cause hemolytic disease of the fetus and newborn. In Switzerland, fetal RHD genotyping from maternal blood has been recommended from gestational age 18 onwards since the year 2020. This facilitates tai

Externí odkaz: https://doaj.org/article/7686d2c99e764ace8e823f7f3584c0cd

Minor intron splicing is regulated by FUS and affected by ALS ‐associated FUS mutants

Autor: Daniel Jutzi, Angela Bachi, Giuseppe Filosa, Stefan Reber, Martino Colombo, Silvia M.L. Barabino, Marc-David Ruepp, Silvia C. Lenzken, Rémy Bruggmann, Jolanda Stettler, Oliver Mühlemann, Christoph Schweingruber

Publikováno v: Europe PubMed Central
Reber, S, Stettler, J, Filosa, G, Colombo, M, Jutzi, D, Lenzken, S C, Schweingruber, C, Bruggmann, R, Bachi, A, Barabino, S M, Mühlemann, O & Ruepp, MD 2016, ' Minor intron splicing is regulated by FUS and affected by ALS-associated FUS mutants ', The EMBO journal, vol. 35, no. 14, pp. 1504-1521 . https://doi.org/10.15252/embj.201593791

Fused in sarcoma (FUS) is a ubiquitously expressed RNA-binding protein proposed to function in various RNA metabolic pathways, including transcription regulation, pre-mRNA splicing, RNA transport and microRNA processing. Mutations in the FUS gene wer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::497c9dc6f0de2d607b0d6c6d18700b48
https://doi.org/10.15252/embj.201593791